Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between 25 µg Vaginal Misoprostol Versus Slow Release Pessary Prostaglandin-E2 (PGE2) : Could we Use Low Dose Vaginal Misoprostol as a First Line Treatment for Induction of Labor ?

NCT01765881 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT01765881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01765881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between 25 µg Vaginal Misoprostol Versus Slow Release Pessary Prostaglandin-E2 (PGE2) : Could we Use Low Dose Vaginal Misoprostol as a First Line Treatment for Induction of Labor ?
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
September 30, 2015
Enrollment
1,700 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

delivery uterine